Author

A. Amen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

I. Bally· 3 shared P. Poignard· 3 shared D. Fenel· 2 shared G. Schoehn· 2 shared M. Buisson· 2 shared A. Fabra-Garcia· 1 shared A.-S. Gallouet· 1 shared C. Bouillier· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

I. Bally

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats

A. Amen, R. Yoo, A. Fabra-Garcia, J. Bolscher, W. J. R. Stone, I. Bally, S. Dergan-Dylon, I. Kucharska, R. M. de Jong, M. de Bruijni, T. Bousema, C. R. King, R. S. MacGill, R. W. Sauerwein, J.-P. Julien, , M. M. Jore

The paper identifies human antibodies targeting Plasmodium falciparum sexual stages, revealing cross-stage recognition of glutamate-rich repeats through a novel method.

bioRxiv · Nov 3, 2023 · PreprintImmunology

Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization using a versatile adenovirus-inspired multimerization platform

C. Chevillard, A. Amen, S. Besson, D. Hannani, I. Bally, V. Dettling, E. Gout, C. J. Moreau, M. Buisson, S. Gallet, D. Fenel, E. Vassal-Stermann, G. Schoehn, P. Poignard, M.-C. Dagher, P. Fender

This paper describes a vaccine platform using adenovirus-inspired nanoparticles decorated with SARS-CoV-2 RBD to elicit potent neutralizing antibodies in mice.

bioRxiv · Sep 13, 2021Microbiology

Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects Macaques from infection

G. Sulbaran, P. Maisonnasse, A. Amen, D. Guilligay, N. Bosquet, J. A. Burger, M. Poniman, M. Buisson, S. D. Dylon, T. Naninck, J. Lemaitre, W. Gros, A.-S. Gallouet, R. Marlin, C. Bouillier, , W. Weissenhorn

This study develops a synthetic SARS-CoV-2 S glycoprotein virus-like particle vaccine that protects macaques from infection through strong antibody and T cell responses.

bioRxiv · Jul 26, 2021Immunology